Virtus Biotech ETF (BBP)

Assets	$125.93M
Expense Ratio	0.34%
PE Ratio	15.32
Forward PE	18.39
Shares Out	1.25M
Dividend	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	14,628
Open	104.52
Previous Close	101.80
Day's Range	104.52 - 104.90
52-Week Low	71.65
52-Week High	110.05
Beta	0.57
Holdings	68
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSE Arca
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

28.02% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	6.01%
Iovance Biotherapeutics, Inc.	IOVA	4.61%
Omeros Corporation	OMER	2.80%
Verastem, Inc.	VSTM	2.49%
Halozyme Therapeutics, Inc.	HALO	2.23%
Precigen, Inc.	PGEN	2.19%
Kiniksa Pharmaceuticals International, plc	KNSA	2.01%
Xeris Biopharma Holdings, Inc.	XERS	1.91%
Rigel Pharmaceuticals, Inc.	RIGL	1.89%
Novavax, Inc.	NVAX	1.89%

Performance

BBP had a total return of 47.24% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.48%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error